DR. GHAZWAN ATTO M.D. NPI 1578553301

NPI Details

DR. Ghazwan Atto, M.D. is an internal medicine in Wyandotte, MI with 31 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Ghazwan Atto, M.D. NPI is 1578553301. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2300 BIDDLE AVE
SUITE 100
WYANDOTTE, MI
ZIP 48192-650
Phone: (734) 246-5705
Fax: (734) 246-5750

The NPI 1578553301 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 23D1003010 - physician office with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Hemoglobin a1c level (HCPCS:83036)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Assessment of emotional or behavioral problems (HCPCS:96127)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Automated urinalysis test (HCPCS:81003)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• X-ray of chest, 2 views (HCPCS:71046)
• Coronavirus vaccine 13 (HCPCS:91312)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Sarscov2 vac 30 mcg trs-sucr (HCPCS:91305)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Influenza vaccine, quadrivalent derived from recombinant dna (HCPCS:90682)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes (HCPCS:99336)
• Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes (HCPCS:99335)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Initial hospital observation care per day, typically 70 minutes (HCPCS:99220)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Hospital observation care on day of discharge (HCPCS:99217)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Face-to-face behavioral counseling for obesity, 15 minutes (HCPCS:G0447)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Blood glucose (sugar) level (HCPCS:82947)
• Follow-up observation care per day, typically 35 minutes (HCPCS:99226)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent (HCPCS:G0250)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Nursing facility discharge management, more than 30 minutes (HCPCS:99316)
• Removal of impacted ear wax by washing (HCPCS:69209)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Hospital observation or inpatient care admitted and discharged on the same day for low severity problem, typically 40 minutes (HCPCS:99234)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• X-ray of hip, 2-3 views (HCPCS:73502)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• X-ray of foot, 2 views (HCPCS:73620)
• Red blood cell concentration measurement (HCPCS:85014)
• X-ray of knee, 1-2 views (HCPCS:73560)
• X-ray of hand, 2 views (HCPCS:73120)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Follow-up observation care per day, typically 25 minutes (HCPCS:99225)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)
• New patient custodial care facility, group care, or assisted living visit, typically 45 minutes (HCPCS:99326)
• X-ray of ankle, 2 views (HCPCS:73600)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring (HCPCS:M0245)
• Injection, bamlanivimab and etesevimab, 2100 mg (HCPCS:Q0245)
• Assessment of and care planning for impaired thought processing, typically 50 minutes (HCPCS:99483)
• X-ray of ribs on side of body, 2 views (HCPCS:71100)
• X-ray of middle spine, 2 views (HCPCS:72070)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test for exercise-induced lung stress (HCPCS:94618)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Initial hospital observation care per day, typically 50 minutes (HCPCS:99219)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Injection, sotrovimab, 500 mg (HCPCS:Q0247)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• X-ray of both knees while standing (HCPCS:73565)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Hospital observation or inpatient care admitted and discharged on the same day for moderate severity problem, typically 50 minutes (HCPCS:99235)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 10/24/2005 and was last updated on 3/31/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.